SLC6A3 and Cognitive impairment: These observations expand upon previous research demonstrating links between altered striatal dopaminergic markers and cognitive impairment in schizophrenia (Takano, 2018) and the positive relationships between reduced striatal DAT availability and attention or memory deficits in our previous work (Yang et al., 2022a).